Good afternoon. My name is Celeste, and I will be your conference operator today. At this time, I would like to welcome everyone to the Mercury General First Quarter Results 2008 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. This conference may contain comments and forward-looking statements based on current plans, expectations, events and financial and industry trends, which may affect Mercury General's future operating results and financial position. Such statements involve risks and uncertainties which cannot be predicted or quantified and which may cause future activities and results of operations to differ materially from those discussed here today. I'd now like to turn today's call to Mr. Gabriel Tirador. Sir, please go ahead.

Thank you very much. I would like to welcome everyone to Mercury's first quarter conference call. I am Gabe Tirador, President and CEO. In the room with me is Mr. George Joseph, Chairman; Ted Stalick, Vice President and CFO; Chris Graves, Chief Investment Officer; John Sutton, Senior Vice President, Customer Service; and Robert Houlihan, Vice President and Chief Product Officer. On the phone, we have Ron Deep, Vice President of the South East Region and Bruce Norman, Senior Vice President of Marketing. Before we open it up for questions, I would like to make a few comments regarding the quarter. In our California operations, our combined ratio increased from 91.2% in the first quarter of 2007 to 94.1% in the first quarter of 2008. The primary reasons for the increase was an increase in auto frequency in the low-single digits, and increase in auto severity in the mid-single digits, adverse development of approximately $5 million, and an increase in our expense ratio. Our California frequency was impacted in the quarter, especially in January and February from significantly higher rainfall amounts as compared to the prior year. The increase in the frequency was seen primarily in our collision coverage. The increase in severity was due to a higher bodily injury and physical damage costs related to higher medical, labor and parts [ph] cost. Our homeowners' results were also negatively impacted by the weather during the quarter, as frequency increased significantly as compared to prior year. In California, we recently implemented new automobile rates. The overall rate impact of this new rate level is an approximately 2.4% rate reduction. In addition, this new rate level gets us very close to full compliance with the new territorial rate regulations. As required by the regulations, we plan on making new filing by July of…

[Operator Instructions]. Your first question comes from the line of Josh Shanker with Citi.

Good morning to you.

Good morning Josh.

I was wondering if you could talk a little about your perceptions of excess capital. And I know that there is not much you can say, but I'm still interested in thoughts about perhaps a share repurchase or even a large share repurchase, if you could get perhaps Gloria to sell shares or what your thoughts are there?

Well, our capital management, as you know Josh, historically has been for us to distribute our capital back to our shareholders through dividends and increasing dividends pretty much every year. That really has not changed, and really don't foresee that to change.

In terms of... can you talk about what you think your excess capital position might be, or even how much more capital you have compared to what you think you need to be operating your business at the current levels?

Well, we have said historically Josh that we would be comfortable writing at a higher premium to surplus ratios. I believe we are in the neighborhood of 1.4

1.6.

1.6 to 1. And we've said in the past that... and we have done this in the past where we burn up to 3 to 1 if not in excess of that. So, our plan, as I said, is to continue to distribute our capital back to shareholders through increased dividends, and use that capital as the market begins to harden. And hopefully here we'll see some top-line growth when that occurs.

Okay. And in terms of overall compensation with the agencies, are you finding that there is much change in terms of commission rates at this point right now? Or do you see that intensifying in terms of some companies paying more?

We have seen... in this market we have seen some companies pay more. We've seen companies with contests increasing commission levels. We've seen some of that. Although, I believe that that will start to diminish as you probably have noticed Josh, the results of some of the major competitors have started to deteriorate.

That's true, that's true. Do you see anyone paying more than 15% commissions out there right now?

On selected basis for some times see for a period of time company come in and say we'll pay you X revenue a the new business policy. But generally, I have got to say that we don't see that often people pay more than 15.

Okay. Well thank you for your answers. I appreciate it.

Thank you.

[Operator Instructions]. Your next question comes from the line Meyer Shields of Stifel Nicolaus. Meyer Shields - Stifel Nicolaus & Company, Inc.: Thanks. Hi everybody.

Hi. Meyer Shields - Stifel Nicolaus & Company, Inc.: Do you see any change to either your levels or competitor rate levels; this is for California personal auto under the Commissioners recent emergency regulations?

Under the emergency regulations? Meyer Shields - Stifel Nicolaus & Company, Inc.: Right.

Well, we're still evaluating those emergency regulations. On the whole, they appear to be a little better than the existing regulations. But we're still in the process of evaluating that, Meyer. Meyer Shields - Stifel Nicolaus & Company, Inc.: Okay. So, right now you don't have any... well let me ask this differently. When you make your next filling in July, do you expect any rate changes in that?

We're still evaluating that. We just, as you know, implemented a small rate reduction that was effective just about a week or two ago. And our actuaries and product management group are working right now and looking at what this next rate that is going to be. Inflation is going up. As I mentioned in my comments, we are seeing severity going up. So depending on how far out you think that rate level is going to be effective, it's possible that you may see some rate change there. Meyer Shields - Stifel Nicolaus & Company, Inc.: That's helpful, thank you. Also, this is a tricky question to ask, obviously Mercury has been decided frequently in the news following Liberty Mutual announced were plan by SAFECO, I don't expect that you want to comment on that, but can you talk a little bit about how county [ph] compatible you think Mercury would be with another company?

Personally, I think we have unique culture at Mercury. And it would be difficult, I think, to match another company's culture. There are some divisional type companies that I've heard of, that appear to have similar culture. But net-net I think that we have a culture that is somewhat unique. Meyer Shields - Stifel Nicolaus & Company, Inc.: Okay. Thank you very much. Very helpful.

[Operator Instructions]. And there are no further questions at this time.

Okay, no further questions. Are you sure?

[Operator Instructions]. You have a follow-up question from the line of Meyer Shields with Stifel Nicolaus.

Okay. Meyer Shields - Stifel Nicolaus & Company, Inc.: Thanks. It just seems like there is time today. If I look at the accident period combined ratios outside of California, we really haven't seen much of a change there. It's been sort of in the mid 100 plus range. If that, should that surprise us?

Well, I think there is a couple of things there, Meyer, that you have to take into consideration is, one is the current accident period is obviously the most difficult to predict. And, we've had a situation like we did in this quarter, where we did bring down some reserves from prior periods, which impacted the calendar year results. We are going to continue to monitor our results going forward with respect to the current accident period. But I can tell you that we are making a lot of changes to our products, as I mentioned earlier, we have... we just filed two rate changes this month. We have another six changes that we want to make in the second quarter, all of which... some of which are increasing rate levels, but in addition to that, improving segmentation. We have found pockets of areas where we clearly are not segmenting our pricing accurately, and all of these things, I think, are going to continue to have a positive impact on our results outside of California, in addition to all the operational improvements that we continue to have outside of California on a claims and underwriting side. So, I guess to answer your question, we are still playing it under current accident year, we are still waiting to see solid results before we bring down any kind of accident, current accident year results. Meyer Shields - Stifel Nicolaus & Company, Inc.: Okay. If I can dig into, I guess, one of your comments, you said that you're seeing areas where your segmentation needs to be improved. Is that based on analysis of your own data or what your competitors are doing?

I will let Robert take that, but it's a little both but

Yes, I would say, it's a little bit both. I would say the primary types of changes we are making are in tiering [ph], where we found that we utilize a number of variables in our in our tiering such as accidents and violations, which we also surcharged for and resulted in some incorrect pricing as a result. And we are simplifying our tearing and improving our segmentation based on internal analysis as well as supplementing that with relativity that are generally used by competitors. Meyer Shields - Stifel Nicolaus & Company, Inc.: Okay. That's very helpful. Thanks so much.

Thank you.

Your next question comes from the line Wan Bobman with Capital Return [ph].

Hi, thanks a lot. I thought we are going to get one more question from Charlie Gates, I guess not. I had two questions with two different topics. I was curious if the recent legislative session in Florida brought forth any legislation that that would impact your auto business there, was my first question?

Why don't you... Ron, you on?

Yes I am. I don't see anything in the revision to the law that is going to be problematic for the automobile side. Most of what is obtained the focus of that law has been to strengthen the Office of Insurance Regulation and to strengthen the prior approval regulations in Florida. But when you look at the country as a whole, most other states that we do business in, have some kind of prior approval regulation already in place.

Okay. And just as a follow up on that one topic. So there was nothing addressed with respect to PIP of late? Is that still as it stood before?

PIP is back in essentially the same format that it left. There are some improvements around who can own some of these treatment centers and some of the fee schedules. But essentially PIP is virtually unchanged, and PIP did not make it to the legislative session this year.

I see. Okay. But it's reinstated as it was before it lapped in partiality?

Yes.

Okay. And I had an unrelated question with respect to bodily injury. And I'm curious to know with respect to sort of medical utilization, if you're seeing any up-tick in BI, which would be attributable, so you sort of... your suspicion of sort of increased utilization, increased number of testing prescribed, et cetera, at the, I guess, the hospital and medical center level. And if you're seeing any of that, if it's localized or if it's geographically spread? Thanks.

I don't know we're seeing really any increased utilization. We are seeing just inflationary pressure in the bodily injury line, in fact, probably in the mid to high-single digits. But I can't really comment on the fact that we're seeing actually increased utilization with respect to the medical.

Do you track the components of BI across sort of different buckets, so you could... so you then would be able to track changes in meaningful buckets whether it be prescription drugs or tests for a certain sort, et cetera, et cetera?

Well, we track medical specials, and we also track the pain and suffering piece. So, we have an idea of how much medical costs are going up versus the other non-component, but don't have a tracking mechanism for a more granular level that you are talking about.

Okay. So it's really like two major buckets comprised in your view.

Yes.

Okay. All right. Thanks a lot and best of luck. I appreciate your time.

Okay. Thank you.

Thank you. [Operator Instructions]. And you have no further question.

Okay. With no further questions, I'd like to thank everyone for being on the call, and we'll talk to you next quarter. Thank you very much.

This concludes today conference call. You may now disconnect.